A preliminary prospectus has been filed by Shockwave Medical for an initial public offering that could bring in $70 million. The firm develops products to treat calcified cardiovascular disease through a process called intravascular lithotripsy, and its Shockwave M5 IVL catheter was cleared by European and US regulators last year.
Sign up for AdvaMed SmartBrief
Medical technology news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.